97 related articles for article (PubMed ID: 21685034)
21. Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma.
Väisänen A; Kallioinen M; Taskinen PJ; Turpeenniemi-Hujanen T
J Pathol; 1998 Sep; 186(1):51-8. PubMed ID: 9875140
[TBL] [Abstract][Full Text] [Related]
22. Histopathological features and clinical course of the gastrointestinal stromal tumors.
Di Matteo G; Pescarmona E; Peparini N; Di Matteo FM; Zeri KP; Mascagni D; Mele R; Maturo A; Redler A; De Antoni E
Hepatogastroenterology; 2002; 49(46):1013-6. PubMed ID: 12143190
[TBL] [Abstract][Full Text] [Related]
23. Micropthalmia transcription factor: a new prognostic marker in intermediate-thickness cutaneous malignant melanoma.
Salti GI; Manougian T; Farolan M; Shilkaitis A; Majumdar D; Das Gupta TK
Cancer Res; 2000 Sep; 60(18):5012-6. PubMed ID: 11016620
[TBL] [Abstract][Full Text] [Related]
24. C-kit expression in canine mucosal melanomas.
Newman SJ; Jankovsky JM; Rohrbach BW; LeBlanc AK
Vet Pathol; 2012 Sep; 49(5):760-5. PubMed ID: 21825314
[TBL] [Abstract][Full Text] [Related]
25. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
Taylor RC; Patel A; Panageas KS; Busam KJ; Brady MS
J Clin Oncol; 2007 Mar; 25(7):869-75. PubMed ID: 17327608
[TBL] [Abstract][Full Text] [Related]
26. Telomerase activity in prognostic histopathologic features of melanoma.
Carvalho L; Lipay M; Belfort F; Santos I; Andrade J; Haddad A; Brunstein F; Ferreira L
J Plast Reconstr Aesthet Surg; 2006; 59(9):961-8. PubMed ID: 16920589
[TBL] [Abstract][Full Text] [Related]
27. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
[TBL] [Abstract][Full Text] [Related]
28. Analysis of KIT expression and gene mutation in human acral melanoma: with a comparison between primary tumors and corresponding metastases/recurrences.
Dai B; Cai X; Kong YY; Yang F; Shen XX; Wang LW; Kong JC
Hum Pathol; 2013 Aug; 44(8):1472-8. PubMed ID: 23528861
[TBL] [Abstract][Full Text] [Related]
29. A case of cutaneous leiomyosarcoma with overexpression of KIT: do CD117 (KIT)-positive primary gastrointestinal stromal tumours of the skin exist?
Horie M; Hatamochi A; Yamazaki S; Izumi M; Mukai K
Br J Dermatol; 2006 May; 154(5):1013-6. PubMed ID: 16634920
[No Abstract] [Full Text] [Related]
30. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.
Liegl B; Hornick JL; Corless CL; Fletcher CD
Am J Surg Pathol; 2009 Mar; 33(3):437-46. PubMed ID: 19011564
[TBL] [Abstract][Full Text] [Related]
31. Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure.
Handolias D; Salemi R; Murray W; Tan A; Liu W; Viros A; Dobrovic A; Kelly J; McArthur GA
Pigment Cell Melanoma Res; 2010 Apr; 23(2):210-5. PubMed ID: 20088873
[TBL] [Abstract][Full Text] [Related]
32. Antigen Ki-67 and c-myc oncogene as related to histoclinical parameters in pigmented skin lesions.
Korabiowska M; Brinck U; Mirecka J; Kellner S; Marx D; Schauer A
In Vivo; 1995; 9(5):433-8. PubMed ID: 8900920
[TBL] [Abstract][Full Text] [Related]
33. Dermatopathological indicators of poor melanoma prognosis are significantly inversely correlated with the expression of NM23 protein in primary cutaneous melanoma.
Ferrari D; Lombardi M; Ricci R; Michiara M; Santini M; De Panfilis G
J Cutan Pathol; 2007 Sep; 34(9):705-12. PubMed ID: 17696918
[TBL] [Abstract][Full Text] [Related]
34. Pediatric nasopharyngeal carcinoma: better prognosis and increased c-Kit expression as compared to adults.
Bar-Sela G; Ben Arush MW; Sabo E; Kuten A; Minkov I; Ben-Izhak O
Pediatr Blood Cancer; 2005 Sep; 45(3):291-7. PubMed ID: 15558705
[TBL] [Abstract][Full Text] [Related]
35. Predicting ten-year survival of patients with primary cutaneous melanoma: corroboration of a prognostic model.
Sahin S; Rao B; Kopf AW; Lee E; Rigel DS; Nossa R; Rahman IJ; Wortzel H; Marghoob AA; Bart RS
Cancer; 1997 Oct; 80(8):1426-31. PubMed ID: 9338466
[TBL] [Abstract][Full Text] [Related]
36. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.
Owen SA; Sanders LL; Edwards LJ; Seigler HF; Tyler DS; Grichnik JM
Cancer; 2001 Mar; 91(5):983-91. PubMed ID: 11251950
[TBL] [Abstract][Full Text] [Related]
37. Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression.
Montone KT; van Belle P; Elenitsas R; Elder DE
Mod Pathol; 1997 Sep; 10(9):939-44. PubMed ID: 9310959
[TBL] [Abstract][Full Text] [Related]
38. The role of nm23 in melanoma progression and its prognostic significance.
Betke H; Korabiowska M; Brinck U; Trybus-Gałuszka H; Kellner S; Okoń K; Stachura J; Droese M
Pol J Pathol; 1998; 49(2):93-6. PubMed ID: 9798412
[TBL] [Abstract][Full Text] [Related]
39. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.
Berk DR; Johnson DL; Uzieblo A; Kiernan M; Swetter SM
Arch Dermatol; 2005 Aug; 141(8):1016-22. PubMed ID: 16103331
[TBL] [Abstract][Full Text] [Related]
40. Study of c-kit immunoexpression in canine cutaneous melanocytic tumors.
Gomes J; Queiroga FL; Prada J; Pires I
Melanoma Res; 2012 Jun; 22(3):195-201. PubMed ID: 22407004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]